These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19489649)

  • 1. Targeted therapy for Kaposi sarcoma.
    Sullivan RJ; Pantanowitz L; Dezube BJ
    BioDrugs; 2009; 23(2):69-75. PubMed ID: 19489649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New drug targets in Kaposi sarcoma.
    Sullivan RJ; Pantanowitz L
    Expert Opin Ther Targets; 2010 Dec; 14(12):1355-66. PubMed ID: 21043836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study.
    Sullivan SG; Hirsch HH; Franceschi S; Steffen I; Amari EB; Mueller NJ; Magouras I; Biggar RJ; Rickenbach M; Clifford GM;
    AIDS; 2010 Sep; 24(14):2245-52. PubMed ID: 20543658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
    Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
    J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapy.
    Wilkinson J; Cope A; Gill J; Bourboulia D; Hayes P; Imami N; Kubo T; Marcelin A; Calvez V; Weiss R; Gazzard B; Boshoff C; Gotch F
    J Virol; 2002 Mar; 76(6):2634-40. PubMed ID: 11861829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
    Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
    Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma--associated herpesvirus infection in patients with and without Kaposi sarcoma.
    Gill J; Bourboulia D; Wilkinson J; Hayes P; Cope A; Marcelin AG; Calvez V; Gotch F; Boshoff C; Gazzard B
    J Acquir Immune Defic Syndr; 2002 Dec; 31(4):384-90. PubMed ID: 12447008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS.
    Quinlivan EB; Wang RX; Stewart PW; Kolmoltri C; Regamey N; Erb P; Vernazza PL;
    J Med Virol; 2001 Jun; 64(2):157-66. PubMed ID: 11360248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity.
    Yarchoan R; Pluda JM; Wyvill KM; Aleman K; Rodriguez-Chavez IR; Tosato G; Catanzaro AT; Steinberg SM; Little RF
    Crit Rev Immunol; 2007; 27(5):401-14. PubMed ID: 18197804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study.
    Letang E; Almeida JM; Miró JM; Ayala E; White IE; Carrilho C; Bastos R; Nhampossa T; Menéndez C; Campbell TB; Alonso PL; Naniche D
    J Acquir Immune Defic Syndr; 2010 Apr; 53(5):589-97. PubMed ID: 19801945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial.
    Krown SE; Lee JY; Lin L; Fischl MA; Ambinder R; Von Roenn JH
    J Acquir Immune Defic Syndr; 2006 Feb; 41(2):149-53. PubMed ID: 16394845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstitution of immune responses against Kaposi sarcoma-associated herpesvirus.
    Flores R; Goedert JJ
    AIDS; 2010 Sep; 24(14):2279-81. PubMed ID: 20616696
    [No Abstract]   [Full Text] [Related]  

  • 14. Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era.
    La Ferla L; Pinzone MR; Nunnari G; Martellotta F; Lleshi A; Tirelli U; De Paoli P; Berretta M; Cacopardo B
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2354-65. PubMed ID: 24065230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia.
    Bourboulia D; Aldam D; Lagos D; Allen E; Williams I; Cornforth D; Copas A; Boshoff C
    AIDS; 2004 Feb; 18(3):485-93. PubMed ID: 15090801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy.
    Boivin G; Gaudreau A; Routy JP
    AIDS; 2000 Sep; 14(13):1907-10. PubMed ID: 10997393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, Portugal.
    Goebel FD; Jablonowski H
    Eur J Med Res; 1999 Dec; 4(12):507-13. PubMed ID: 10611054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Runaway Kaposi Sarcoma-associated herpesvirus replication correlates with systemic IL-10 levels.
    Caro-Vegas C; Sellers S; Host KM; Seltzer J; Landis J; Fischer WA; Damania B; Dittmer DP
    Virology; 2020 Jan; 539():18-25. PubMed ID: 31629226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for Kaposi sarcoma herpesvirus: great challenges with promising accomplishments.
    Arav-Boger R
    Virus Genes; 2009 Apr; 38(2):195-203. PubMed ID: 19139983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen.
    Lin SF; Sun R; Heston L; Gradoville L; Shedd D; Haglund K; Rigsby M; Miller G
    J Virol; 1997 Apr; 71(4):3069-76. PubMed ID: 9060668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.